Trials / Completed
CompletedNCT03697382
Effect of Daily Steps on Fat Metabolism
Effect of Daily Ambulatory Activity on the Responses to Acute Aerobic Exercise.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University of Texas at Austin · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Reduced ambulatory activity has been shown to effect the response to a high fat tolerance test (HFTT) after acute exercise. This study will evaluate the effect of varying levels of daily ambulation on response to a HFTT after an acute aerobic exercise bout.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Very Low Steps | Subjects will have a 2-day control period during which step count and diet will be controlled for and recreated for the other trials. Following this 2-day period, they will undergo the Very Low Stepping trial with the acute bout of exercise on day 2. Day 3 will consist of the lipid tolerance test to determine the ability of the body to clear triglycerides. |
| BEHAVIORAL | Low Steps | Subjects will have a 2-day control period during which step count and diet will be controlled for and recreated for the other trials. Following this 2-day period, they will undergo the Low Stepping trial with the acute bout of exercise on day 2. Day 3 will consist of the lipid tolerance test to determine the ability of the body to clear triglycerides. |
| BEHAVIORAL | Moderate Steps | Subjects will have a 2-day control period during which step count and diet will be controlled for and recreated for the other trials. Following this 2-day period, they will undergo the Moderate Stepping trial with the acute bout of exercise on day 2. Day 3 will consist of the lipid tolerance test to determine the ability of the body to clear triglycerides. |
Timeline
- Start date
- 2018-09-29
- Primary completion
- 2020-02-15
- Completion
- 2020-05-31
- First posted
- 2018-10-05
- Last updated
- 2021-09-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03697382. Inclusion in this directory is not an endorsement.